	TROP2				TM9SF2				TSPAN6				NGFR
	Area (%)	p	Score	p	Area (%)	p	Score	p	Area (%)	p	Score	p	Area (%)	p	Score	p
Gender
Male	65.3	0.44	82.0	0.26	83.1	0.23	125.6	0.26	86.3	0.10	144.7	0.93	73.7	0.31	98.7	0.75
Female	67.3		103.3		77.8		121.4		93.6		146.3		80.7		102.8
Age
<65	66.6	0.36	103.3	0.15	82.3	0.86	131.5	0.19	85.6	0.24	141.8	0.69	80.0	0.29	106.1	0.30
≥65	66.1		88.1		79.4		117.6		92.8		149.2		72.5		92.5
Location
Colon	58.0	0.21	91.0	0.48	85.4	0.31	140.9	0.35	86.2	0.62	138.7	0.36	76.8	0.89	100.0	0.80
Rectum	75.3		97.6		79.3		116.2		87.7		138.8		78.0		102.0
Histological grade
WD	67.5	0.42	92.5	0.35	80.0	0.71	110.0	0.56	88.8	0.87	148.8	0.86	75.0	0.93	100.0	0.73
MD	61.7		83.4		79.5		132.0		89.5		145.0		76.5		99.0
PD	100.0		170.0		95.0		95.0		80.0		120.0		90.0		120.0
Stage
Early	60.8	0.43	85.0	0.58	76.8	0.38	111.8	0.28	94.4	0.11	150.0	0.74	75.2	0.44	99.0	0.70
Late	70.0		97.7		85.0		137.1		86.6		143.3		81.1		104.4
T stage
T1-T2	80.0	0.53	115.0	0.60	86.0	0.59	122.0	0.95	90.0	0.91	135.0	0.67	85.0	0.34	120.0	0.22
T3-T4	65.3		91.0		79.1		123.7		89.0		147.0		75.2		96.4
Lymph node metastasis
Negative	58.8	0.11	88.2	0.66	76.8	0.38	111.8	0.27	95.8	0.04	159.1	0.22	75.2	0.44	99.0	0.70
Positive	76.1		98.4		85.0		137.1		84.4		136.1		81.1		104.4
CEA
<5	61.8	0.41	81.1	0.38	77.3	0.51	112.6	0.36	89.4	0.93	148.8	0.67	72.8	0.35	95.0	0.50
≥5	71.4		103.5		83.5		134.2		88.4		140.7		79.3		104.0
5-year survival
<5	71.6	0.45	106.6	0.31	85.0	0.31	140.0	0.12	91.7	0.33	154.7	0.25	78.3	0.75	105.8	0.52
≥5	62.7		83.3		75.7		105.0		85.3		133.0		76.1		97.2